Shares of MSCI Inc (NYSE: MSCI) rose 5.53% Friday.

As of 12:03:14 est, MSCI sits at $407.77 and has risen $21.46 so far today.

MSCI has moved 19.01% over the last 30 days and has a YTD change of 36.38% based on the prior day’s close.

The company anticipates its next earnings on 2022-07-26.

For technical charts, analysis, and more on MSCI visit the company profile.

About MSCI Inc

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data and technology, MSCI powers better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. MSCI creates industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process.

To get more information on MSCI Inc and to follow the company's latest updates, you can visit the company's profile page here: MSCI Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold

The Best Laid Plans of Mice and Men — Part I

Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users

Squarespace Beats Revenue Estimates With Record Q1

BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million

How To Trade in a Bearish Market

AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement